class action lawsuit

Smart Digital Group's stock crashed 86.4% after alleged fraud scheme; investors have until March 16 to join class action lawsuit.

Former Cushman & Wakefield employee sues company for allegedly breaching ERISA duties by failing to address climate risks in 401(k) plans, potentially setting precedent for $12 trillion U.S. retirement market.

Robbins LLP sues Mereo BioPharma over setrusumab trial failures; stock crashes 87.7% to $0.29 after December 29 announcement.

Richtech Robotics faces securities lawsuit after Microsoft denied commercial partnership claimed in January press release. Stock surged 30% then fell 20% following the clarification.

Class action filed against Ardent Health alleging $57.5M EBITDA overstatement and revenue misstatement following accounting system implementation failure.

Ramaco Resources faces class action securities fraud lawsuit over alleged misrepresentation of Wyoming Brook Mine operations; eligible shareholders must file claims by March 31, 2026.

Plug Power faces securities fraud lawsuit over allegedly false DOE loan claims. PLUG shareholders have until April 3, 2026 to file in class action.

Law Offices of Howard G. Smith launches securities fraud suits against $VRNS, $CRWV, $BBWI, and Ardent Health. Investors have until March 2026 to file lead plaintiff motions.

Class action lawsuit filed against $UGDX alleging false statements about setrusumab efficacy for Osteogenesis Imperfecta, claiming Phase III results overstated drug benefits.

Class action lawsuit filed against Richtech Robotics for falsely claiming commercial partnership with Microsoft's AI Co-Innovation Labs, triggering sharp stock decline.

Class action lawsuit filed against BellRing Brands alleging materially false statements about sales performance driven by inventory accumulation rather than genuine demand.

China Liberal Education ($CLEUF) faces class action over 240M hidden shares causing 98.1% stock collapse and NASDAQ delisting. Lawsuit deadline is March 31, 2026.

Class action lawsuit filed against $INO for allegedly false statements about INO-3107 treatment and CELLECTRA device. Lead plaintiff deadline is April 7, 2026.

Boston Scientific faces securities fraud investigation after 17.6% stock drop triggered by weaker-than-expected electrophysiology division sales in Q4 2025 results.

Class action lawsuit filed against Enphase Energy alleging securities fraud related to undisclosed channel inventory and tax credit impact concerns between April 2025 and October 2025.

uniQure stock plunges 49% after FDA rejects gene therapy data for AMT-130, triggering securities fraud class action lawsuit for investors trading September-October 2025.

Kyndryl Holdings faces securities fraud lawsuit over internal control failures and executive departures. Stock crashed 55% after delayed 10-Q filing disclosure.

Law firm Kahn Swick & Foti files class action against $UGXX over failed Phase 3 trial for rare bone disease drug setrusumab. Investors can apply as lead plaintiffs by April 6.

Kahn Swick & Foti, LLC filed class action lawsuits against Navan, Kyndryl, and Ultragenyx for alleged securities disclosure violations. Lead plaintiff applications due April 24, 2026.

CoreWeave faces class action securities fraud lawsuit alleging overstatement of capacity and understatement of supplier risks between March-December 2025. Lead plaintiff applications due March 13, 2026.